longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Starling Oncology

STLN

6.4650.69% ( -0.045 )
Trading: Sep 30, 11:47:55 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -21.71, within the reasonable range, cheaper than 65.85% of the time in the past 1 years, and the industry ranks 22/23, the industry Median 13.66.

-21.71xP/E
$6.51Stock price
$-0.30Earnings per share
-21.71xP/E
Stock price$6.51Earnings per share$-0.30

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-21.07x
Typical range
-22.11x–-20.31x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 13.66x
05101520

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 13.66x
0x10x20x30x40x50x
P/E ratio
Name/Symbol
BKDUSBrookdale Senior Living
-18.96x102.39%$2.62B
ACHCUSAcadia Healthcare
-2.32x107.17%$2.61B
SGRYUSSurgery Partners
-21.29x3.28%$1.89B
SNDAUSSonida Senior Living
-12.43x14.93%$1.81B
STLNUSStarling Oncology
-21.71x70.00%$663.47M
IVPRUSInspire Veterinary Partners, Inc.
-0.00x--$44.88K
RNVAUSRennova Health, Inc.
----$40.55K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.